Literature DB >> 11027516

Transactivation of fibronectin promoter by HTLV-I Tax through NF-kappaB pathway.

T Yi1, B H Lee, R W Park, I S Kim.   

Abstract

The facts that fibronectin (FN) mRNA is elevated in cells expressing human T cell leukemia virus type I (HTLV-I) Tax protein and that Tax is known to transactivate the cellular cAMP-response element (CRE) prompted us to examine whether Tax activates the FN promoter of which CRE is thought to play an important role. We showed that Tax transactivated the FN promoter in Jurkat cells. Deletion analyses showed that the response-element resides within the promoter region of -69 bp and that an NF-kappaB-binding site at -41 bp is involved in the Tax-activation of the FN promoter. Gel-shift assays showed that DNA-protein complexes binding to the NF-kappaB site, composed of NF-kappaB p50/p65, were induced on the NF-kappaB motif at -41 bp by Tax. Overexpression of NF-kappaB enhanced the Tax-activation of the FN promoter. Our study shows that the FN promoter is transactivated by Tax through the NF-kappaB pathway. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027516     DOI: 10.1006/bbrc.2000.3517

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses.

Authors:  Ana-Monica Pais-Correia; Martin Sachse; Stéphanie Guadagnini; Valentina Robbiati; Rémi Lasserre; Antoine Gessain; Olivier Gout; Andrés Alcover; Maria-Isabel Thoulouze
Journal:  Nat Med       Date:  2009-12-20       Impact factor: 53.440

2.  Hypertrophic scar contracture is mediated by the TRPC3 mechanical force transducer via NFkB activation.

Authors:  Hisako Ishise; Barrett Larson; Yutaka Hirata; Toshihiro Fujiwara; Soh Nishimoto; Tateki Kubo; Ken Matsuda; Shigeyuki Kanazawa; Yohei Sotsuka; Kazutoshi Fujita; Masao Kakibuchi; Kenichiro Kawai
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.